Show simple record

dc.contributor.authorBowles, Danielle
dc.contributor.authorRobson, Mark
dc.contributor.authorGalloway, Pru
dc.contributor.authorWalker, Lyndon
dc.date.accessioned2011-11-20T23:02:08Z
dc.date.available2011-11-20T23:02:08Z
dc.date.issued2010-02
dc.identifier.issn0022-4510
dc.identifier.urihttp://hdl.handle.net/10652/1722
dc.description.abstractOBJECTIVES: To determine owners’ perception of their pet’s quality of life during treatment with carboplatin for a variety of canine and feline neoplasms. METHODS: Owners were contacted via a postal questionnaire and asked questions regarding their perception of chemotherapy in pets and their perception of carboplatin treatment in their pet. RESULTS: Twenty-eight (59%) of owners responded to the questionnaire. Forty-three percent of owners had not considered chemotherapy in pets before treatment; however, after treatment, 89% of owners supported its use. Sixteen (57%) patients had mild to severe side effects. Most patients experienced mild side effects, including lethargy and loss of appetite. Quality of life during treatment was reduced compared with prediagnosis quality of life however at its best was significantly improved compared with pretreatment quality of life. Eighty-nine per cent of respondents did not regret treating their pet. CLINICAL SIGNIFICANCE: Carboplatin is well tolerated by both owners and pets. Most patients have either no side effects or experience mild lethargy or inappetence. Carboplatin treatment, either alone or in conjunction with other medications, should be considered as a palliative treatment in both dogs and cats with susceptible neoplasms.en_NZ
dc.language.isoenen_NZ
dc.publisherWiley-Blackwellen_NZ
dc.relation.urihttp://onlinelibrary.wiley.com/doi/10.1111/j.1748-5827.2009.00891.x/pdfen_NZ
dc.rightsThe definitive version of this article is available at http://onlinelibrary.wiley.com/.en_NZ
dc.subjectcarboplatinen_NZ
dc.subjectquality of lifeen_NZ
dc.subjectpalliative careen_NZ
dc.subjectfeline neoplasmen_NZ
dc.subjectcanine neoplasmen_NZ
dc.titleOwners’ perception of carboplatin in conjunction with other palliative treatments for cancer therapyen_NZ
dc.typeJournal Articleen_NZ
dc.rights.holderBritish Small Animal Veterinary Associationen_NZ
dc.identifier.doi10.1111/j.1748-5827.2009.00891.xen_NZ
dc.subject.marsden070706 Veterinary Medicineen_NZ
dc.identifier.bibliographicCitationBowles, D., Robson, M., Galloway, P., & Walker, L. (2010). Owners’ perception of carboplatin in conjunction with other palliative treatments for cancer therapy. Journal of Small Animal Practice, 51(2), 104–112. doi: 10.1111/j.1748-5827.2009.00891.xen_NZ
unitec.institutionUnitec Institute of Technologyen_NZ
unitec.publication.spage104en_NZ
unitec.publication.lpage112en_NZ
unitec.publication.volume51en_NZ
unitec.publication.titleJournal of Small Animal Practiceen_NZ
unitec.peerreviewedyesen_NZ


Files in this item

Thumbnail

This item appears in

Show simple record